Quick Answer
Syra Health Corp reported Stockholders Equity of $2.10 million for the year ending 2025.
- Syra Health Corp showed a decrease of -27.1% in Stockholders Equity from 2024 to 2025.
- This data is from Syra Health Corp's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $1.16 million | Q3 2022: $1.32 million | Q1 2023: -$74.4 thousand | Q2 2023: -$876.0 thousand | Q3 2023: -$1.23 million | Q1 2024: $3.45 million | Q2 2024: $2.09 million | Q3 2024: $3.33 million | Q1 2025: $2.46 million | Q2 2025: $2.41 million | Q3 2025: $2.21 million.
- Over the full 5 years of available data (2021 to 2025), Syra Health Corp's Stockholders Equity has grown by 29,457.5%.
- Historical annual values: Fiscal year 2025: $2.10 million | Fiscal year 2024: $2.88 million | Fiscal year 2023: $4.01 million | Fiscal year 2022: $710.1 thousand | Fiscal year 2021: -$7.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: